Back
NeoGenomics Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison
Sell
49
NEO
NeoGenomics
Last Price:
14.91
Seasonality Move:
2.01%
Buy
65
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
48.42
Seasonality Move:
-8.14%
Sell
49
NeoGenomics (NEO)
is a Sell
Is NeoGenomics a Buy, Sell or Hold?
- The current NeoGenomics [NEO] share price is $14.91. The Score for NEO is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- NEO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
Corbus Pharmaceuticals Holdings (CRBP)
is a Buy
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $48.55. The Score for CRBP is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- CRBP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NEO Stock Price Chart
What is NeoGenomics's stock price today?
-
The NeoGenomics share price today is $14.91
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NEO is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $48.55
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRBP is experiencing buying pressure, which is a positive indicator for future bullish movement.
NEO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.14 | Buy |
| Relative Strength Index (14 RSI): | 50 | Sell |
| Chaikin Money Flow: | 368218 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.89 - 15.39) | Buy |
| Bollinger Bands (100): | (14.29 - 16.17) | Sell |
CRBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.31 | Buy |
| Relative Strength Index (14 RSI): | 71.39 | Buy |
| Chaikin Money Flow: | 219957 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.04 - 43.7) | Buy |
| Bollinger Bands (100): | (16.28 - 42.74) | Buy |
NEO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.27 | Sell |
| 20-day SMA: | 14.88 | Buy |
| 50-day SMA: | 14.8 | Buy |
| 200-day SMA: | 15.25 | Sell |
| 8-day EMA: | 15.08 | Sell |
| 20-day EMA: | 14.96 | Sell |
| 50-day EMA: | 14.96 | Sell |
| 200-day EMA: | 15.33 | Sell |
CRBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.53 | Buy |
| 20-day SMA: | 40.26 | Buy |
| 50-day SMA: | 39.82 | Buy |
| 200-day SMA: | 17.7 | Buy |
| 8-day EMA: | 44.58 | Buy |
| 20-day EMA: | 41.89 | Buy |
| 50-day EMA: | 37.98 | Buy |
| 200-day EMA: | 23.02 | Buy |
NeoGenomics Earnings Growth & NEO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.03 per share, an increase this year of $0.20 per share, and an increase next year of $0.14 per share.
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.55 per share, an increase next quarter of $0.28 per share, an increase this year of $5.53 per share, and an increase next year of $0.35 per share.
NeoGenomics Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corbus Pharmaceuticals Holdings Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||